78
Views
24
CrossRef citations to date
0
Altmetric
Original Research

miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway

, , , &
Pages 4087-4095 | Published online: 16 Jul 2018

References

  • TorreLABrayFSiegelRLGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • CedoliniCBertozziSLonderoAPType of breast cancer diagnosis, screening, and survivalClin Breast Cancer201414423524024703317
  • RudolphAChang-ClaudeJSchmidtMKGene-environment interaction and risk of breast cancerBr J Cancer2016114212513326757262
  • JemalACenterMMDesantisCWardEMGlobal patterns of cancer incidence and mortality rates and trendsCancer Epidemiol Biomarkers Prev20101981893190720647400
  • LiuRZGarciaEGlubrechtDDCRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acidMol Cancer20151412926142905
  • AdamsBDKasinskiALSlackFJAberrant regulation and function of microRNAs in cancerCurr Biol20142416R762R77625137592
  • BhaskaranMMohanMMicroRNAs: history, biogenesis, and their evolving role in animal development and diseaseVet Pathol201451475977424045890
  • DongYChangCLiuJQiangJTargeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivoOnco Targets Ther2017105873588229270025
  • LiuBLiJCairnsMJIdentifying miRNAs, targets and functionsBrief Bioinform201415111923175680
  • di LevaGGarofaloMCroceCMMicroRNAs in cancerAnnu Rev Pathol2014928731424079833
  • SongBLinHXDongLLMaJJJiangZGMicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathwayEur Rev Med Pharmacol Sci20182251290129629565486
  • QuanJPanXHeTTumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinomaExp Ther Med20181544019402829581751
  • QinCHuangRYWangZXPotential role of miR-100 in cancer diagnosis, prognosis, and therapyTumour Biol20153631403140925740059
  • BertoliGCavaCCastiglioniIMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerTheranostics20155101122114326199650
  • LiuMYangRUrrehmanUMiR-19b suppresses PTPRG to promote breast tumorigenesisOncotarget2016739641006410827602768
  • NicoliniAFerrariPKotlarovaLRossiGBiavaPMThe PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast CancerCurr Pharm Biotechnol201516980481526201609
  • NagasawaSSedukhinaASNakagawaYLSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibitionPLoS One2015102e011800225679396
  • EsfahaniMAtaeiNPanjehpourMBiomarkers for evaluation of prostate cancer prognosisAsian Pac J Cancer Prev20151672601261125854335
  • MochHSrigleyJDelahuntBBiomarkers in renal cancerVirchows Arch2014464335936524487793
  • HanSXZhouXSuiXSerum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancerOncotarget2015623199071991726101916
  • LiWWangYZhangQMicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung CancerPLoS One2015108e013422026237047
  • ChenJWangXMicroRNA-21 in breast cancer: diagnostic and prognostic potentialClin Transl Oncol201416322523324248894
  • ChenQGZhouWHanTMiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancerJ Cancer Res Clin Oncol2016142121322426227059
  • XiaMDuanMLTongJHXuJGJgXMiR-26b suppresses tumor cell proliferation, migration and invasion by directly targeting COX-2 in lung cancerEur Rev Med Pharmacol Sci201519244728473726744864
  • MuhammadNBhattacharyaSSteeleRRayRBAnti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3Oncotarget2016736585955860527517632
  • TangWXuPWangHMicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2Onco Targets Ther2018112319233229731640
  • LiPDongJZhouXExpression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancerOnco Targets Ther2017105711571829238203
  • OhiraTNaohiroSNakayamaYmiR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cellsSci Rep20155820125643913
  • LiXWangFSWuZYZyWMicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cellsNeoplasma201461326527324824927
  • ZhaoLZhaoYHeYMaoYmiR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion moleculesOncotarget2017838643306434328969074
  • WuCCaoYHeZSerum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancerTohoku J Exp Med20142322859524531034
  • ZhangTJLinJZhouJDHigh bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemiaGene2018640798529032147
  • XuXMWangXBChenMMMicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5Cancer Lett2012322214815822561557
  • TianLFangYXXueJLChenJZFour microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitroPLoS One201389e7588524098737
  • PolivkaJJankuFMolecular targets for cancer therapy in the PI3K/AKT/mTOR pathwayPharmacol Ther2014142216417524333502
  • DanielsenSAEidePWNesbakkenAPortrait of the PI3K/AKT pathway in colorectal cancerBiochim Biophys Acta20151855110412125450577